News

A Phase I trial involving ten patients with relapsed or refractory classical Hodgkin lymphoma or T-cell lymphoma has achieved ...
T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety ...
T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety profile in patients with two types of advanced thyroid cancer, according to ...
Researchers sought to assess the access to CAR-T therapy for patients within community-based and transplant cell therapy networks.
Gene sequencing enabled researchers to identify the specific milk protein that triggered a patient’s eosinophilic esophagitis ...
Scientists investigated how social relationship strength and oxytocin receptor expression could underlie individual ...
Clean Up the Formatting . An Excel sheet with inconsistent formatting can look ugly. You can use the Format Painter to copy ...
A rare cell type in the lungs is essential to survival from the COVID-19 virus, a new study shows. Experiments in mice ...
Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.
The team tested the impact on eight novel helper plasmids with different deletions in the E2 and E4 genes on four rAAV serotypes. They discovered that some deletions affected productivity, reducing ...